{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T22:44:07Z","timestamp":1781909047302,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"eli lilly and company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014422","name":"eli lilly japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s13300-021-01124-9","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T15:58:34Z","timestamp":1628611114000},"page":"2471-2484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long-term Efficacy and Safety of Ultra Rapid Lispro in Japanese Patients With Type 1 Diabetes: Subpopulation Analysis of the 52-Week PRONTO-T1D Study"],"prefix":"10.1007","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct03214367","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Junnosuke","family":"Miura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Imori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"key":"1124_CR1","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.2337\/dc12-2258","volume":"36","author":"S Stark Casagrande","year":"2013","unstructured":"Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988\u20132010. Diabetes Care. 2013;36:2271\u20139.","journal-title":"Diabetes Care"},{"key":"1124_CR2","first-page":"S1","volume":"42","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. Standards of medical care in diabetes-2019 abridged for primary care providers. Diabetes Care. 2018;42:S1.","journal-title":"Diabetes Care"},{"key":"1124_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dc13-2112","volume":"37","author":"DM Nathan","year":"2014","unstructured":"Nathan DM. The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37:9\u201316.","journal-title":"Diabetes Care"},{"key":"1124_CR4","unstructured":"Japan Diabetes Clinical Data Management Study Group. 2018. https:\/\/jddm.jp\/data\/index-2017.html#data_03. Accessed 09 Nov 2020."},{"key":"1124_CR5","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2337\/dc14-0031","volume":"37","author":"G Grunberger","year":"2014","unstructured":"Grunberger G. Insulin analogs-are they worth it? Yes! Diabetes Care. 2014;37:1767\u201370.","journal-title":"Diabetes Care"},{"key":"1124_CR6","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1177\/193229681200600402","volume":"6","author":"L Heinemann","year":"2012","unstructured":"Heinemann L, Muchmore DB. Ultrafast-acting insulins: state of the art. J Diabetes Sci Technol. 2012;6:728\u201342.","journal-title":"J Diabetes Sci Technol"},{"key":"1124_CR7","doi-asserted-by":"crossref","unstructured":"Ishii H, Shuichi S, Williams P, Demiya S, Aranishi T, Treuer T. Cross-sectional survey in patients with type 1 and type 2 diabetes to understand mealtime insulin unmet needs in Japan: the MINUTES-J study. Diabetes Res Clin Pract. 2020;2020:108076.","DOI":"10.1016\/j.diabres.2020.108076"},{"key":"1124_CR8","unstructured":"Pharmaceutical and Medical Devices Agency. Summary of investigation results. Preparations containing insulin. 2020. https:\/\/www.pmda.go.jp\/files\/000235075.pdf#page=4. Accessed 09 Nov 2020."},{"key":"1124_CR9","doi-asserted-by":"publisher","unstructured":"Haahr H, Heise T. Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences. Clin Pharmacokinet. 2020;59(2):155\u201372. https:\/\/doi.org\/10.1007\/s40262-019-00834-5.","DOI":"10.1007\/s40262-019-00834-5"},{"key":"1124_CR10","first-page":"975","volume":"66","author":"ELJ Pratt","year":"2017","unstructured":"Pratt ELJ, Heilmann C, Johnson J, Landshulz W. Treprostinil causes local vasodilation, is well tolerated, and results in faster absorption of insulin lispro. Diabetes. 2017;66:975.","journal-title":"Diabetes"},{"key":"1124_CR11","first-page":"66","volume":"2017","author":"JSZC Moyers","year":"2017","unstructured":"Moyers JSZC, Siesky AM, et al. Exploration of the mechanism of accelerated absorption for a novel insulin lispro formulation. Diabetes. 2017;2017:66.","journal-title":"Diabetes"},{"key":"1124_CR12","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1111\/dom.14094","volume":"22","author":"T Heise","year":"2020","unstructured":"Heise T, Linnebjerg H, Coutant D, et al. Ultra rapid lispro lowers postprandial glucose and more closely matrefches normal physiological glucose response compared to other rapid insulin analogues: a phase 1 randomized, crossover study. Diabetes Obes Metab. 2020;22:1789\u201398.","journal-title":"Diabetes Obes Metab"},{"key":"1124_CR13","doi-asserted-by":"publisher","unstructured":"Klaff L, Cao D, Dellva MA, et al. Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: results from the 26-week PRONTO-T1D study. Diabetes Obes Metab. 2020;22(10):1799\u20131807. https:\/\/doi.org\/10.1111\/dom.14100.","DOI":"10.1111\/dom.14100"},{"key":"1124_CR14","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s13300-020-00892-0","volume":"11","author":"J Miura","year":"2020","unstructured":"Miura J, Imori M, Nishiyama H, Imaoka T. Ultra-rapid lispro efficacy and safety compared to Humalog(\u00ae) in Japanese patients with type 1 diabetes: PRONTO-T1D subpopulation analysis. Diabetes Ther. 2020;11:2089\u2013104.","journal-title":"Diabetes Ther"},{"issue":"2","key":"1124_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s13300-020-00987-8","volume":"12","author":"J Bue-Valleskey","year":"2021","unstructured":"Bue-Valleskey J, Klaff L, Cho JI, Dellva MA, et al. Long-term efficacy and safety of ultra rapid lispro (URLi) in adults with type 1 diabetes: the PRONTO T1D extension. Diabetes Ther. 2021;12(2):569\u201380. https:\/\/doi.org\/10.1007\/s13300-020-00987-8.","journal-title":"Diabetes Ther"},{"issue":"6","key":"1124_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2337\/diacare.4.6.579","volume":"4","author":"MI Schmidt","year":"1981","unstructured":"Schmidt MI, Hadji-Georgopoulos A, Rendell M, Margolis S, Kowarski A. The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation. Diabetes Care. 1981;4(6):579\u201385. https:\/\/doi.org\/10.2337\/diacare.4.6.579.","journal-title":"Diabetes Care"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01124-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-021-01124-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01124-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T07:59:03Z","timestamp":1629791943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-021-01124-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1124"],"URL":"https:\/\/doi.org\/10.1007\/s13300-021-01124-9","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,4]]},"assertion":[{"value":"18 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}